All articles by Vishnu Priyan

Genelux doses first subject in Phase II trial of NSCLC treatment

Genelux has dosed the first subject in the Phase II VIRO-25 clinical trial in the US, designed to assess the…
Galderma reports data from Phase III trial of anti-ageing product RelabotulinumtoxinA

Swiss skincare company Galderma has reported positive data from a Phase III clinical trial of RelabotulinumtoxinA (Relfydess) for treating moderate-to-severe…
Find Therapeutics dosing subjects in study of FTX-101 for chronic optic neuropathy

Canadian biopharmaceutical company Find Therapeutics has dosed the first subject in a Phase I trial of its lead compound, FTX-101,…
Lutris ends subject enrolment in EGFRI-induced acneiform rash trial

Lutris Pharma has concluded subject enrolment in its Phase II clinical trial of LUT014, a new B-Raf inhibitor designed for…
Airway Therapeutics to trial drug for bronchopulmonary dysplasia in newborn babies

US-based biotechnology company Airway Therapeutics is to launch a multinational Phase III clinical trial of zelpultide alfa, a drug designed…

Exelixis and MSD to trial cancer therapies together in clinical collaboration

US-based biotechnology companies Exelixis and MSD have partnered to assess the potential of combining their respective cancer therapies in upcoming…
GSK’s depemokimab shows promise in Phase III trials for chronic rhinosinusitis

UK-based pharmaceutical company GSK has announced positive results from the Phase III ANCHOR-1 and ANCHOR-2 clinical trials of depemokimab in…
Repare Therapeutics doses first subject in Phase I solid tumour trial

Repare Therapeutics has dosed the first subject in its Phase I POLAR clinical trial of RP-3467, a Polθ ATPase inhibitor,…
CEPI to initiate Phase II trials of a Rift Valley fever vaccine in Kenya

The Coalition for Epidemic Preparedness Innovations (CEPI) is preparing to initiate Phase II clinical trials for a human vaccine candidate…
Mater Research initiates combined Covid-flu vaccine trial

Mater Research in Brisbane, Australia, has commenced a clinical trial for a new combined Covid-19 and flu vaccine from Novavax…